Every financial statement,
one clean chart.
Search any US-listed company. Data straight from SEC filings.
RHYTHM PHARMACEUTICALS, INC. (RYTM), most recent 12 months reported: revenue $239.92M, net loss $205.35M, free cash flow -$116.63M. Latest balance sheet on file: liquid cash $330.9M, total debt $106.1M, net cash $224.79M. From SEC filings. More on RHYTHM PHARMACEUTICALS, INC.: Revenue · Profitability · Cash flow · Debt Others in Pharmaceutical Preparations: RIGEL PHARMACEUTICALS, INC. · Harrow, Inc. · Schrodinger, Inc. · Syndax Pharmaceuticals, Inc. · PHATHOM PHARMACEUTICALS, INC. · ANAPTYSBIO, INC. · IDEAYA Biosciences, Inc. · PUMA BIOTECHNOLOGY, INC.
Filter every US company by the numbers — net cash, margins, ROIC, growth. Looking for one company? The search box above is free.
Follow a company and we'll email you when it files a quarterly or annual report with the SEC. Free follows 3 companies; Pro follows up to 500, and sorts and filters them.